Lauren Santye, Assistant Editor

Marc O'Connor, CEO and chief strategy officer of Curant Health, discusses how projected drug spending growth will alter the specialty pharmacy landscape in the future.

Study provides better understanding of why some cancers are resistant to therapy.

Prickly pear and brown seaweed extracts provide hope for age-related diseases.

The diabetic effects on surgical outcomes found to be overstated.

Symptoms significantly worsened in patients treated with MS drug alemtuzumab.

Top news of the day from across the health care landscape.

FDA approves first generic version of Xyrem (sodium oxybate) Oral Solution for the treatment of cataplexy and daytime sleepiness in patient with narcolepsy.

Cataplexy causes sudden muscle tone loss while awake, including voluntary muscle control.

Agency releases guidelines to determine the interchangeability of biosimilars with their reference products.

Guidance intends to help sponsors demonstrate Interchangeability with a reference product.

Real-time reporting of patient symptoms has shown proven health benefits.

Histone H3 protein is abnormal or incorrectly modified in 15% of patients with head and neck cancer.

Study confirms safety and efficacy of Lu-177-PSMA-17 radioligand therapy for metastatic castration-resistant prostate cancer.

South African Pharmacy Council lifts ban preventing pharmacies from selling DIY HIV test kits.

CanChew Plus CBD gum may eventually treat irritable bowel disease, Crohn’s disease, and ulcerative colitis.

Top news of the day from across the health care landscape.

Requirements will vary based on the nature of the proposed interchangeable product, and may include an evaluation of data and information generated to support a demonstration of a biological product’s biosimilarity.

BRCA2-inherited prostate cancers are predisposed to turn treatment resistant.

The CDC developed a new technique to measure marijuana’s active compounds in milk.

Top news of the day from across the health care landscape.

Anti-TNFs reduce severity and incidence of myocardial infarction in RA patients.

Top news of the day from across the health care landscape.

Improved treatment options for patients with relapsing-remitting multiple sclerosis and primary progressive multiple sclerosis.

Identified cancer driver may be key to increasing survival in metaplastic breast cancer patients.

Immune checkpoint blockade and gene therapy more effective together than alone in brain cancer.

Certain psychoactive drugs increase stroke risk by 20% among Alzheimer’s patient population.

New at-risk group for skin cancer identified.

Biological products will be designated with 4-letter suffixes devoid of meaning.

FDA finalizes guidance for nonproprietary naming of biological products.

Americans living in rural areas more likely to die from top 5 causes of death, including cancer.